Premier Perspectives

The blog for insider insights in clinical development

Premier Voices Podcast

Conversations with Premier's subject matter experts
PREMIER VOICES #15: Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients

PREMIER VOICES #15

Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients
PREMIER VOICES #14: Setting a Real-World Strategy in an Evolving Clinical Research Environment

PREMIER VOICES #14

Setting a Real-World Strategy in an Evolving Clinical Research Environment
PREMIER VOICES #13: Early-Phase Oncology – Emerging From the Crisis & Innovating for the Future

PREMIER VOICES #13

Early-Phase Oncology – Emerging From the Crisis & Innovating for the Future
PREMIER VOICES #12: Direct-to-Patient – Is This the ‘New Normal’ for Clinical Trials?

PREMIER VOICES #12

Direct-to-Patient – Is This the ‘New Normal’ for Clinical Trials?
PREMIER VOICES #11: Statistical Considerations in the Wake of COVID-19

PREMIER VOICES #11

Statistical Considerations in the Wake of COVID-19
PREMIER VOICES #10: COVID-19 Update – How the FDA's Emergency Use Authorization Can Help Develop Therapies Faster

PREMIER VOICES #10

COVID-19 Update – How the FDA's Emergency Use Authorization Can Help Develop Therapies Faster
PREMIER VOICES #9: COVID-19 Update – What Sponsors Need to Know About the New FDA Guidance

PREMIER VOICES #9

COVID-19 Update – What Sponsors Need to Know About the New FDA Guidance
Premier Voices #8: Engaging Patients in Clinical Trials w/ Alan Thomas

Premier Voices #8

Engaging Patients in Clinical Trials w/ Alan Thomas
Premier Voices #7: Rare Disease Advocacy & International Ataxia Day w/ Alan Thomas (Ataxia & Me)

Premier Voices #7

Rare Disease Advocacy & International Ataxia Day w/ Alan Thomas (Ataxia & Me)
Premier Voices #6: Operationalizing the New MDR With Janet Kube (Part 2)

Premier Voices #6

Operationalizing the New MDR With Janet Kube (Part 2)